The safety and efficacy of treatment with phentermine ( PHEN ) / topiramate ( TPM ) extended release ( ER ) plus lifestyle modification for weight loss and glycemic benefits were assessed in two randomized , double-blind , placebo-controlled 56-week studies of obese/overweight adults with type 2 diabetes .